Medication info
Sitagliptin Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)

Sitagliptin Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Bright brown, round, bilaterally convex film-coated tablet
Packaging
28 tablets/PTP [(14 tablets/PTP x 2)]
Approval status
Active

MFDS item code 202101176 · Approved 2021.02.08 · Insurance code 622804850

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, section 5, General Precautions). Patients with renal impairment As dose adjustment is required according to renal function, assessment of renal function before and periodically after starting this medicine is recommended. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medicine helps with blood sugar control in patients with type 2 diabetes by supplementing dietary and exercise therapy. It can be used alone, and if previous diabetes medications have not been used or if blood sugar control is difficult with monotherapy, it can be used in combination with metformin. It is also administered in combination when blood sugar control is insufficient with any one of sulfonylurea, metformin, thiazolidinedione, or insulin monotherapy. This medicine helps improve blood sugar levels when additional combination therapy is needed to control blood sugar levels with various combinations of medications. Therefore, this medicine is effective in improving blood sugar control at various stages of treatment for patients with type 2 diabetes.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, section 5, General Precautions). Patients with renal impairment As dose adjustment is required according to renal function, assessment of renal function before and periodically after starting this medicine is recommended. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medicine may cause severe allergic reactions after administration, so if symptoms such as rash or difficulty breathing occur, use should be stopped immediately, and consultation with a physician is required. If symptoms of acute pancreatitis, such as abdominal pain, nausea, or vomiting occur during treatment with this medicine, immediate notification to healthcare professionals is necessary, and use should be discontinued if pancreatitis is suspected. This medicine should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should also not be administered in cases of hypersensitivity to this medicine or its components. Patients with reduced kidney function may have delayed excretion of this medicine, so dose adjustment is necessary, and regular kidney function tests should be performed. In clinical trials, common side effects reported were upper respiratory tract infections, nasopharyngitis, and headaches, and the risk of hypoglycemia may increase when taken together with insulin or sulfonylureas. If severe arthralgia or bullous eruptions occur during treatment with this medicine, inform a physician immediately and discontinue use. Women who are pregnant or nursing are advised not to take this medicine, and safety has not been established for children or adolescents under 18 years of age. Elderly patients should be cautious of dose adjustment and kidney function monitoring as they may have reduced kidney function. In the event of overdose, general treatment can be administered, and blood dialysis may be performed if necessary to remove the medicine. Interactions with other drugs are relatively few; however, caution is needed when taken with cyclosporine or digoxin, and consultation with healthcare professionals is required.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevation of liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine must be stored in a tightly sealed container to prevent air ingress, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. This helps to maintain the medicine's effectiveness.

Appearance and packaging

Appearance

Bright brown, round, bilaterally convex film-coated tablet

Package unit

28 tablets/PTP [(14 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.